Lauren Blakley, MA, MLIS
Clinical Program Analyst
Service: Clinical
Robert Wilder Blue
Navigation Consultant
Robert Wilder Blue is a social worker and public health educator, with expertise in HIV biomedical prevention (PrEP/PEP) program creation, management, and evaluation, and PrEP navigation training and capacity building. He has worked for the San Francisco Department of Public Health, San Francisco City Clinic, and the San Francisco AIDS Foundation.
His experience includes work in HIV vaccine and PrEP research, as well as many years of direct client service in sexual health and wellbeing counseling and case management, with special focus on underserved communities.
Kelly Johnson, MD, MPH
Medical Director
Dr. Kelly Johnson is the Medical Director of the California Prevention Training Center, a Public Health Medical Officer in the STD Control Branch at the California Department of Public Health, and an Assistant Professor of Medicine in the Division of Infectious Diseases at the University of California San Francisco (UCSF). She is board-certified in both Internal Medicine and Infectious Diseases, and works on the inpatient Infectious Diseases service at UCSF. Her research interests include the intersection between HIV and bacterial STIs as well as real-world implementation of HIV PrEP.
Elizabeth Olson, MPH
Clinical Program Manager
Elizabeth Olson plans and implements CDC-funded STI clinical updates in the five-state regional area to prevent, reduce and treat STIs throughout the United States. She has a background in research, education, prevention, and advocacy around health disparities both domestic and international. She earned an MPH from Tufts University in 2011.
Ina Park, MD, MS
Principal Investigator
Dr. Ina Park, MS, is the Principal Investigator at the California Prevention Training Center. She is a Professor in the Department of Family and Community Medicine at the University of California San Francisco School of Medicine and a Medical Consultant in the Division of STD Prevention at the Centers for Disease Control and Prevention.
She is a co-author of the 2021 CDC STD Treatment Guidelines, the country’s premier resource for diagnosis and treatment of sexually transmitted infections. Dr. Park is also the author of Strange Bedfellows: Adventures in the Science, History, and Surprising Secrets of STDs.
Rosalyn Plotzker, MD, MPH
Clinical Faculty
Dr. Rosalyn Plotzker is an assistant professor in the UCSF Department of Epidemiology and Biostatistics, and also performs high-resolution anoscopy at the UCSF Anal Neoplasia Clinic, Research, and Education (ANCRE) Center.
Rosalyn completed a fellowship in Sexually Transmitted Diseases with CAPTC and the California Department of Public Health where she also currently serves as a public health medical officer and clinical lead for congenital syphilis prevention. She also leads efforts to improve HIV prevention and STD screening with the California Office of AIDS. Finally, Rosalyn directs the Virtual Approach to Gynecology Project, a virtual reality gynecologic training module for medical trainees.
STD Clinical Update Webinar – Maternal & Congenital Syphilis Update for CA Prenatal Care Providers
Syphilis among women and congenital syphilis are on the rise in California. Congenital syphilis is preventable with prompt detection and treatment during syphilis. Dr. Eric Tang of the California Department of Public Health (CDPH) and California Prevention Training Center (CAPTC) discusses prenatal care provider knowledge in management of maternal and congenital syphilis for pregnant patients.
Dr. Tang covers the following learning objectives for this webinar:
- Describe California’s CS epidemiology
- Recognize the clinical manifestations of CS
- Discuss CS diagnosis, evaluation, and management
- Report all laboratory-confirmed and clinically-suspected cases of CS to public health
STD Expert Hour Webinar – Understanding the Concerning Rise in Maternal and Congenital Syphilis in Hawaii
Oct 13, 2020
The California Prevention Training Center (CAPTC) and the STI/HIV Prevention Program at the Hawaiʻi Department of Health’s (HIDOH) Harm Reduction Services Branch present this webinar for healthcare providers and community service providers who work with communities that face cultural, economic, and language barriers to obtaining good prenatal and neonatal care.
This webinar will address the increasing rate of syphilis cases within Hawaii, with a special focus on maternal syphilis and congenital syphilis. Learners will gain an understanding of the local epidemiology of syphilis as well as the important role the Hawaii Department of Health performs in syphilis case follow-up and investigation. An overview of the pathophysiology of syphilis with its varied clinical manifestations will be discussed. Content will include the importance of staging, stage-based treatment as well as best practices for diagnosis and follow-up.
CDC Viral Hepatitis Professional Tools
CDC’s compilation of resources for diagnosing and managing hepatitis A, B, and C.
STD Expert Hour Webinar – Delivering Sexual Health Services in the Time of COVID-19
August 13, 2020
The coronavirus (COVID-19) is impacting the delivery of sexual health services in California and throughout the United States. Dr. Ina Park and Dr. Rosalyn Plotzker provide an overview of recent CDC recommendations for STD diagnosis and treatment when in-person exams and visits are limited. They also discuss best practices for the use of telehealth and home-testing for STD care and PrEP management.
Drs. Park and Plotzker cover the following learning objectives for this webinar:
- Share implementation strategies for self-collected testing to minimize clinician exposure to COVID-19 when seeing clients for STD-related symptoms
- Identify changes to recommended syndromic treatment of urethritis, including treatment for gonorrhea and chlamydia
- Describe management recommendations for patients with genital ulcer disease
- Discuss HIV PrEP telehealth management approaches to ensure continuation of PrEP use for clients who are unable to get care in a clinic setting during and after the COVID-19 public health emergency